Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors

PHASE3RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Colorectal Cancer
Interventions
DRUG

Dexmedetomidine administered intranasally

Intranasal administration of dexmedetomidine (plain) was given at the bedside of the ward as per the pre-tested recommended dose. The patient's vital signs were maintained. On the day of surgery, 30 min before induction of anesthesia, intranasal dexmedetomidine (original solution) was administered in the operating room at the pre-tested recommended dose.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

First Affiliated Hospital of Chongqing Medical University

OTHER